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The emergence and evolutionary expansion of gene
families implicated in cancers and other severe
genetic diseases is an evolutionary oddity from
a natural selection perspective. Here, we show that
gene families prone to deleterious mutations in the
human genome have been preferentially expanded
by the retention of ‘‘ohnolog’’ genes from two rounds
of whole-genome duplication (WGD) dating back
from the onset of jawed vertebrates. We further
demonstrate that the retention of many ohnologs
suspected to be dosage balanced is in fact indirectly
mediated by their susceptibility to deleterious muta-
tions. This enhanced retention of ‘‘dangerous’’ ohno-
logs, defined as prone to autosomal-dominant dele-
terious mutations, is shown to be a consequence of
WGD-induced speciation and the ensuing purifying
selection in post-WGD species. These findings high-
light the importance of WGD-induced nonadaptive
selection for the emergenceof vertebrate complexity,
while rationalizing, from an evolutionary perspective,
the expansion of gene families frequently implicated
in genetic disorders and cancers.
INTRODUCTION
Just as some genes happen to be more ‘‘essential,’’ owing to
their deleterious loss-of-function or null mutations, some genes
can be classified as more ‘‘dangerous,’’ due to their propensity
to acquire deleterious gain-of-function mutations. This is, in
particular, the case for oncogenes and genes with autoinhibitory
protein folds, whose mutations typically lead to constitutively
active mutants with dominant deleterious phenotypes (Pufall
and Graves, 2002).
Dominant deleterious mutations, that are lethal or drastically
reduce fitness over the lifespan of organisms, must have also
impacted their long term evolution on timescales relevant for
genome evolution (e.g., >10–100 million years [MY]). In fact,
dominant disease genes in humans have been shown to be
under strong purifying selection (Furney et al., 2006; Blekhman
et al., 2008; Cai et al., 2009). Yet, ‘‘dangerous’’ gene familiesCell Reimplicated in cancer and severe genetic diseases have also
been greatly expanded by duplication in the course of vertebrate
evolution. For example, the single orthologous locus, Ras85D in
flies and Let-60 in nematodes, has been duplicated into three
RAS loci in typical vertebrates, KRAS, HRAS, and NRAS, that
present permanently activating mutations in 20%–25% of all
human tumors, even though HRAS and NRAS have also been
shown to be dispensable for mouse growth and development
(Ise et al., 2000; Esteban et al., 2001).
While the maintenance of essential genes is ensured by
their lethal null mutations, the expansion of dangerous gene
families remains an evolutionary puzzle from a natural selection
perspective. Indeed, considering that many vertebrate disease
genes are phylogenetically ancient (Domazet-Loso and Tautz,
2008; Cai et al., 2009; Dickerson and Robertson, 2012), and
that their orthologs also cause severe genetic disorders in extant
invertebrates (Berry et al., 1997; Ciocan et al., 2006; Robert,
2010), it is surprising that dangerous gene families have been
duplicated more than other vertebrate genes without known
dominant deleterious mutations. While gene duplicates can
confer mutational robustness against loss-of-function muta-
tions, multiple copies of genes prone to gain-of-function muta-
tions are expected to lead to an overall aggravation of a species’
susceptibility to genetic diseases and thus be opposed by puri-
fying selection.
Two alternative hypotheses can be put forward to account for
the surprising expansion of dangerous gene families. Either, the
propensity of certain genes to acquire dominant deleterious
mutations could be a mere by-product of their presumed advan-
tageous functions. In that case, only the overall benefit of gene
family expansion should matter, irrespective of the mechanism
of gene duplication. Alternatively, gene susceptibility to domi-
nant deleterious mutations could have played a driving role in
the striking expansion of dangerous gene families. But what
could have been the selection mechanism?
In this article, we report converging evidences supporting the
latter hypothesis and propose a simple evolutionary model to
explain the expansion of such dangerous gene families. It is
based on the observation that the majority of human genes
prone to dominant deleterious mutations, such as oncogenes
and genes with autoinhibitory protein folds, have not been dupli-
cated through small scale duplication (SSD). Instead, the expan-
sion of these dangerous gene families can be traced back to two
rounds of whole-genome duplication (WGD), that occurred at theports 2, 1387–1398, November 29, 2012 ª2012 The Authors 1387
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Figure 1. Prevalence of Retained Ohnologs in the Human Genome within Different Gene Classes
(A and B) Prevalence of retained ohnologs either ‘‘w/ SSD or CNV’’ or ‘‘w/o SSD & CNV’’ for all 20,506 human protein-coding genes (A), and gene classes
susceptible to deleterious mutations (B). Note that gene classes with higher susceptibility to deleterious mutations retained more ohnologs.
(C) Ohnolog retention in gene classes susceptible to dosage balance constraints. Fold changes in ohnolog/nonohnolog ratios are given relative to the reference
from all human genes in (A).
See also Figure S1.onset of jawed vertebrates, some 500 MY ago (Ohno, 1970; Put-
nam et al., 2008).
These two rounds of WGD in the early vertebrate lineage are
frequently credited with creating the conditions for the evolution
of vertebrate complexity. Indeed, WGD-duplicated genes, so-
called ‘‘ohnologs’’ in honor of Susumu Ohno (Ohno, 1970; Wolfe,
2000), have been preferentially retained in specific gene classes
associated with organismal complexity, such as signal transduc-
tion pathways, transcription networks, and developmental
genes (Maere et al., 2005; Blomme et al., 2006; Freeling and
Thomas, 2006; Se´mon andWolfe, 2007;Makino andMcLysaght,
2010; Huminiecki and Heldin, 2010). By contrast, gene dupli-
cates coming from SSD are strongly biased toward different
functional categories, such as antigen processing, immune
response, and metabolism (Huminiecki and Heldin, 2010). SSD
paralogs and WGD ohnologs also differ in their gene expression
and protein network properties (Hakes et al., 2007; Guan et al.,
2007). Furthermore, recent genome-wide analysis have shown
that ohnologs in the human genome have experienced fewer
SSD than ‘‘nonohnolog’’ genes and tend to be refractory to
copy number variation (CNV) caused by polymorphism of small
segmental duplications in human populations (Makino and
McLysaght, 2010). These antagonist retention patterns of WGD
and SSD/CNV gene duplicates in the human genome have
been suggested to result from dosage balance constraints (Ma-
kino and McLysaght, 2010) on the relative expressions of
multiple protein partners (Veitia, 2002), as proposed earlier for
other organisms like yeast (Papp et al., 2003) and the parame-
cium (Aury et al., 2006).
In this article, we investigate the evolutionary causes respon-
sible for the expansion of gene families prone to deleterious
mutations in vertebrates and propose a simple evolutionary
model accounting for their antagonistic retention pattern after
WGD and SSD events. The retention of ohnologs in the human
genome is shown to be more strongly associated with their1388 Cell Reports 2, 1387–1398, November 29, 2012 ª2012 The Autsusceptibility to deleterious mutations, than their functional
importance or ‘‘essentiality.’’ We also demonstrate using
a causal inference analysis, that the retention of many ohnologs
suspected to be dosage balanced is in fact an indirect effect of
their higher susceptibility to deleterious mutations. We argue
that the enhanced retention of dangerous ohnologs is a some-
what counterintuitive yet simple consequence of the speciation
event triggered by WGD and the ensuing purifying selection in
post-WGD species.
These findings rationalize, from an evolutionary perspective,
the WGD expansion of gene families frequently implicated in
genetic disorders, such as cancer, and highlight the importance
of nonadaptive selection on the emergence of vertebrate
complexity.
RESULTS
Genes Prone to Deleterious Mutations Retain More
Ohnologs
We first analyzed a possible association between the suscepti-
bility of human genes to deleteriousmutations and their retention
of ohnologs, as proposed in Gibson and Spring (1998) for multi-
domain proteins. To this end, we considered multiple classes of
genes susceptible to deleterious mutations from experimentally
verified databases and literature. These classes include cancer
genes (from multiple sources including COSMIC [Forbes et al.,
2011] and CancerGenes [Higgins et al., 2007]), genes mutated
in other genetic disorders, dominant negative genes from
OMIM, and genes with autoinhibitory protein folds (Experimental
Procedures). We looked at the relative contributions ofWGD and
SSD in the expansion of these ‘‘dangerous’’ gene classes.
The results, depicted in Figures 1 and S1, demonstrate indeed
a strong association between the retention of human ohnologs
from vertebrate WGD and their reported susceptibility to delete-
rious mutations, as compared to nonohnologs, whereas anhors
opposite pattern is found for SSD/CNV gene duplicates. Overall,
the 8,095 human genes associated with the occurrence of
cancer and other genetic diseases have retained significantly
more ohnologs than expected by chance, 48% versus 35%
(48%; 3,844/8,095; p = 1.33 10129, c2 test). Furthermore, these
associations, which do not take into account the actual severity
of the gene mutations, are clearly enhanced when the analysis is
restricted to genes with direct experimental evidence of domi-
nant deleterious mutations, such as dominant disease genes
(59%; 261/440; p = 1.7 3 1027, c2 test), dominant negative
mutants (61%; 292/477; p = 3.9 3 1034, c2 test), oncogenes
(61%; 493/813; p = 1.4 3 1054, c2 test), or genes exhibiting
autoinhibitory constraints (76%; 350/461; p = 2.7 3 1077, c2
test). The biased retention of ohnologs is even stronger for genes
combining several factors associated with an enhanced suscep-
tibility to deleterious mutations, such as cancer genes with auto-
inhibitory folds, (80%; 294/369; p = 1.0 3 1073, c2 test), or
oncogenes with autoinhibitory folds, (91%; 104/114; p = 6.9 3
1037, c2 test).
This retention of dangerous ohnologs is illustrated on Table 1
that presents an up-to-date list of 76 hand-curated gene families
of up to four ohnologs, exhibiting both autoinhibitory folds and
oncogenic properties (see Table S1 for oncogenic and autoinhi-
bitory details and references). These dangerous ohnologs are
typically found along signal transduction cascades, from
receptor tyrosine kinases and cytoplasmic or nuclear kinases
to guanine exchange factors (GEF), GTPase activating proteins
(GAP), and transcription factors (Table 1, gene classes A–E). In
addition, autoinhibited oncogenes are also found in other ohno-
log families with diverse functions (Table 1, gene class F). By
contrast, we obtained a hand-curated list of only ten nonohnolog
genes exhibiting both autoinhibitory and oncogenic properties,
Table 1, gene class G (see Table S2 for oncogenic and autoinhi-
bitory details and references). Interestingly, half of them (4/10)
can be traced back to SSD events, which occurred after or at
the same period of the two WGD in early vertebrate lineages
(Table S2). All in all, this implies that >90% of known oncogenes
with autoinhibitory folds have retained at least one ohnolog pair
in the human genome (as well as, possibly, a few additional
duplicates from more recent SSD events).
Ohnologs Are Conserved but More ‘‘Dangerous’’ than
‘‘Essential’’
We then investigated whether the susceptibility of ohnologs to
deleterious mutations could be directly quantified through
comparative sequence analysis. We used Ka/Ks ratio estimates,
which measure the proportion of nonsynonymous substitutions
(Ka) to the proportion of synonymous substitutions (Ks)
(Extended Results and Table S3). Ohnologs exhibit statistically
lower Ka/Ks ratios, Figures 2, S2, and S3, which provides direct
evidence of strong conservation, consistent with a higher
susceptibility of ohnologs to deleterious mutations. Similar
trends have also been reported for ohnologs specific to teleost
fishes (Brunet et al., 2006) or to themore recentWGD in Xenopus
laevis lineage (Se´mon and Wolfe, 2008). Note, however, that the
functional consequences of such deleterious mutations, leading
either to a gain or a loss of function, cannot be directly inferred
from Ka/Ks distributions. Yet, as outlined below, we foundCell Remarked differences in the retention of ‘‘dangerous’’ ohnologs
prone to dominant gain-of-function mutations and ‘‘essential’’
ohnologs exhibiting lethal loss-of-function or null mutations.
While autosomal-dominant disease genes exhibit a strong
ohnolog retention bias (Figure 1B), 59% versus 35% (59%;
261/440; p = 1.73 1027, c2 test), autosomal-recessive disease
genes are not significantly enriched in ohnologs 37% versus
35% (37%; 221/598; p = 0.24, c2 test). Similarly, human ortho-
logs of mouse genes, reported as being ‘‘essential’’ genes
from large-scale null mutant studies in mouse, are not strongly
enriched in ohnologs 56% versus 54% (56%; 1,537/2,729; p =
3.8 3 103, c2 test), where 54% = 3,190/5,956 is the global
proportion of ohnologs among the 5,956 genes tested for null
mutation in mouse (Experimental Procedures). In fact, this small
enrichment becomes even nonsignificant once genes with domi-
nant allelic mutants are removed from the list of 5,956 genes
tested for essentiality in mouse, i.e., 50% versus 48% (50%;
760/1,525; p = 0.09, c2 test), where 48% = 1,782/3,739 is the
global proportion of ohnologs among the 3,739 genes tested
for essentiality in mouse, after removing dominant disease
genes, oncogenes, and genes with dominant negative mutations
or autoinhibitory folds.
All in all, this shows that the retention of ohnologs has been
most enhanced for genes prone to autosomal-dominant delete-
rious mutations and not autosomal-recessive deleterious muta-
tions. This suggests that the retention of ohnologs is more
strongly related to their ‘‘dangerousness,’’ as defined by their
high susceptibility to dominant deleterious mutations, than their
functional importance or ‘‘essentiality,’’ as identified through
large-scale null mutation studies in mouse.
Ultimately, we will argue that the ‘‘dangerousness’’ of ohno-
logs effectively controls their individual retention in the genomes
of post-WGD species, as will be shown below in the section
Model for the Retention of Dangerous Ohnologs.
Mixed Susceptibility of Human Ohnologs to Dosage
Balance
An alternative hypothesis, focusing instead on the collective
retention of interacting ohnologs, has been frequently invoked
to account for the biased retention of ohnologs in unicellular
organisms like yeast (Papp et al., 2003) or the paramecium
(Aury et al., 2006) and in higher eukaryotes (Birchler et al.,
2001; Makino and McLysaght, 2010).
This ‘‘dosage balance’’ hypothesis posits that interacting
protein partners tend to maintain balanced expression levels in
the course of evolution, in particular, for protein subunits of
conserved complexes (Birchler et al., 2001; Veitia, 2002; Papp
et al., 2003; Veitia, 2010; Makino and McLysaght, 2010). Thus,
SSD of dosage balanced genes are thought to be generally detri-
mental through the dosage imbalance they induce, thereby
raising the odds for their rapid nonfunctionalization (Papp
et al., 2003; Maere et al., 2005). By contrast, rapid nonfunction-
alization of ohnologs after WGD has been suggested to be
opposed by dosage effect, in particular, for highly expressed
genes and genes involved in protein complexes or metabolic
pathways (Aury et al., 2006; Evlampiev and Isambert, 2007;
Gout et al., 2010; Makino andMcLysaght, 2010). This is because
WGD initially preserves correct relative dosage betweenports 2, 1387–1398, November 29, 2012 ª2012 The Authors 1389
Table 1. Ohnolog Families with Both Autoinhibitory and Oncogenic Properties
A. Ohnolog Receptor Tyrosine Kinases and Other Receptor Kinases
ALK LTK KIT CSF1R FLT3
EGFR ERBB2 ERBB3 ERBB4 MET MST1R
FGFR1 FGFR2 FGFR3 FGFR4 NPRA NPRB
IGF1R INSR INSRR PDGFRA PDGFRB
B. Ohnolog Cytoplasmic and Nuclear Protein Kinases
ABL1 ABL2 PKN1 PKN2 PKN3
ARAF BRAF RAF1 PRKAA1 PRKAA2
AKT1 AKT2 AKT3 PRKCA PRKCB PRKCG
CAMK1 CAMK1D CAMK1G PNCK PRKCE PRKCH
CAMKK1 CAMKK2 PRKCI PRKCZ
CSNK1D CSNK1E PRKD1 PRKD2 PRKD3
GSK3A GSK3B PRKG1 PRKG2
GRK4 GRK5 GRK6 PTK2 PTK2B
JAK1 JAK2 JAK3 TYK2 RSK1 RSK2 RSK3 RSK4
SRC FGR FYN YES1 MSK1 MSK2
HCK LCK BLK LYN NDR1 NDR2
MKNK1 MKNK2 SYK ZAP70
NEK6 NEK7
C. Ohnolog GEF
ARHGEF3 NET1 RALGDS RGL1 RGL2 RGL3
ARHGEF6 COOL1 SOS1 SOS2
DBL DBS MCF2L2 TIAM1 TIAM2
FGD1 FGD2 FGD3 FGD4 TIM WGEF SGEF NGEF
PDZ-RHOGEF LSC LARG VAV1 VAV2 VAV3
P114-RHOGEF GEF-H1
D. Ohnolog GAP
ASAP1 ASAP2 ASAP3 PLXNA1 PLXNA2 PLXNA3 PLXNA4
IQGAP1 IQGAP2 IQGAP3 PLXNB1 PLXNB2 PLXNB3 PLXND1
E. Ohnolog DNA Binding and Transcription Factors
CEBPA CEBPB CEBPE IRF4 IRF8 IRF9
CUX1 CUX2 MEIS1 MEIS2 MEIS3
ELK1 ELK3 ELK4 p53 p63 p73
ETS1 ETS2 RUNX1 RUNX2 RUNX3
ETV1 ETV4 ETV5 SOX1 SOX2 SOX3
ETV6 ETV7
F. Other Ohnolog Genes with Both Autoinhibitory and Oncogenic Properties
ANP32A ANP32B ANP32E nNOS eNOS
ATP2B1 ATP2B2 ATP2B3 ATP2B4 NOTCH1 NOTCH2 NOTCH3
cIAP1j2 XIAP PLCB1 PLCB2 PLCB3
CCNT1 CCNT2 PLCD1 PLCD3 PLCD4
FLNA FLNB FLNC PLCG1 PLCG2
FURIN PCSK4 PTPN1 PTPN2
KPNA2 KPNA7 SMURF1 SMURF2
NEDD4 NEDD4L TRPV1j3 TRPV2 TRPV4 TRPV5j6
NOXA1 NOXA2
G. Nonohnolog Genes with Both Autoinhibitory and Oncogenic Properties
CAMK4 ELF3 MELK MOS PDPK1 BRK PTPN11 RET RPS6KB1 TTN
GEF, guanine exchange factors; GAP, GTPase activating proteins.
See also Tables S1 and S2.
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Figure 2. Ka/Ks Distributions for WGD and SSD or CNV Duplicates in the Human Genome
(A–D) Ka/Ks distributions for human-human (Hs-Hs) ohnolog pairs (A) and human-amphioxus (Hs-Bf) ortholog pairs (B) with different confidence status (see
Extended Results). Ka/Ks distributions for human-amphioxus (Hs-Bf) ortholog pairs involving a human ohnolog (C) and for human-amphioxus (Hs-Bf) ortholog
pairs exhibiting either SSD or CNV (D).
See also the Extended Results, Figures S2 and S3, and Table S3 for statistical significance and comparison with other invertebrate outgroups.expressed genes, whereas subsequent random nonfunctionali-
zation of individual ohnologs disrupts this initial dosage balance.
For instance, yeast Saccharomyces cerevisiae has retained 76%
of its ribosomal gene ohnologs from a 150 MY old WGD (Kellis
et al., 2004; Lin et al., 2007), although the maintenance of these
ohnologs has been suggested to require frequent gene conver-
sion events (Kellis et al., 2004; Evangelisti and Conant, 2010)
aswell as fine-tuned dosage compensation to ensure a balanced
expression with the remaining 24% ribosomal genes having lost
their ohnologs (Zeevi et al., 2011).
Following on this dosage balance hypothesis, we performed
statistical analysis on multiprotein complexes from HPRD (Ke-
shava Prasad et al., 2009) and CORUM (Ruepp et al., 2010) data-
bases and a hand-curated list of permanent complexes (Zanivan
et al., 2007) (Experimental Procedures) to investigate for
a possible association between the retention of human ohnologs
and their susceptibility to dosage balance constraints.
The results depicted in Figure 1C demonstrate, in agreement
with (Makino and McLysaght, 2010), that genes implicated in
multiprotein complexes have retained significantly more ohno-
logs than expected by chance, 41% versus 35% (41%; 1,567/
3,814; p = 8.7 3 1017, c2 test). This trend is also enhanced
when focusing on haploinsufficient genes, that are known for
their actual sensitivity to dosage balance constraints (Qian and
Zhang, 2008) (54%; 179/330; p = 8.0 3 1014, c2 test).
Yet, surprisingly, an opposite trend corresponding to the elim-
ination of ohnologs is observed for genes implicated in perma-
nent complexes, that are presumably strongly sensitive toCell Redosage balance constraints (7.5%; 18/239; p = 1.2 3 1018, c2
test) (Figure 1C). In fact, looking more closely at the few human
ohnologs, that have not been eliminated from permanent
complexes (Table 2), we found that they are likely under less
stringent dosage balance constraints than most proteins in
permanent complexes, as they typically coassociate with mito-
chondrial proteins or form large multimeric subcomplexes with
intrinsic stoichiometry disequilibrium.
This suggests that the elimination of most ohnologs from
permanent complexes is, in fact, strongly favored under dosage
imbalance and becomes likely inevitable once a few of those oh-
nologs have been accidentally lost following WGD. Indeed, the
uneven elimination of ohnologs in permanent complexes is ex-
pected to lead to the assembly of nonfunctional, partially formed
complexes detrimental to the cell, unless dosage compensation
mechanisms effectively re-establish proper dosage balance at
the level of gene regulation (Birchler et al., 2001), as for yeast
ribosomal proteins (Zeevi et al., 2011). By contrast, transient
complexes, which are typically more modular than permanent
complexes, are expected to accommodate such dosage
changes more easily, as they do not usually require the same
strict balance in the expression levels of their protein partners.
These findings on the differences in retention of human ohno-
logs between permanent andmore transient complexes suggest
the relevance of different underlying causes. Although dosage
balance presumably remains the primary evolutionary constraint
in permanent complexes (<2% of human genes), which lead to
the elimination of ohnologs in permanent complexes inports 2, 1387–1398, November 29, 2012 ª2012 The Authors 1391
Table 2. Low Retention of Ohnologs in Permanent Complexes
Permanent Complexesa Number of Ohnologs Intrinsic Stoichiometry Disequilibrium of Ohnologs in Permanent Complexes
ATP F0 3/12 the 3 ohnologs ATP5G1-3 form the 10-mer C-ring of the F-type ATP synthase
ATP F1 0/5
COX 2/11 the 2 ohnologs COX4I1,2 coassemble with 3 mitochondrial encoded genes
SRS 2/32 Ohnologs are X-linked RPS4X (with no X-inactivation) and Y-linked RPS4Y1
Mitochondrial SRS 0/30
LRS 2/50 RPL3 and RPL39 have ohnologs RPL3L and RPL39L with unknown functions
Mitochondrial LRS 0/48
Proteasome 2/31 ohnologs PSMA7 or PSMA7L are included in the 2 rings of 7 a subunits
Pyruvate dehydrogenase 0/5
RNA Pol II 0/12
RNA Pol III 0/9
COX, cytochrome c oxidase; LRS, large ribosomal subunit; SRS, small ribosomal subunit.
aZanivan et al., 2007.vertebrate genomes, gene susceptibility to deleterious muta-
tions may be more relevant for the retention of ohnologs within
the 17% of human genes participating in more transient
complexes. For instance, transient complexes involved in phos-
phorylation cascades or GTPase signaling pathways are known
to bemore sensitive to the level of activation of their protein part-
ners than to their total expression levels. Thus, although the
active forms of multistate proteins typically amount to a small
fraction of their total expression level, hence providing a large
dynamic range for signal transduction, it alsomakes thempartic-
ularly susceptible to gain-of-function mutations. Such mutations
can shift protein activation levels 10- to 100-fold without
changes in expression levels and likely underlie stronger evolu-
tionary constraints than the 2-fold dosage imbalance caused
by gene duplication.
Indirect Cause of Ohnolog Retention in Protein Complex
To further investigate the relative effects of dosage balance and
gene susceptibility to deleterious mutations, we analyzed
whether the overall enhanced retention of ohnologs within multi-
protein complexes (Figure 1C) could indirectly result from an
enhanced susceptibility to deleterious mutations. Indeed, as
outlined in Figure 3A, cancer and disease genes are more prev-
alent within complexes than expected by chance, 29% versus
19% (29%; 2,362/8,095; p = 3.73 10132, c2 test) and this trend
is enhanced for genes with stronger susceptibility to deleterious
mutations, such as oncogenes (39%; 320/813; p = 2.9 3 1052,
c2 test) or oncogenes with autoinhibitory folds (59%; 67/114; p =
2.9 3 1028, c2 test). By contrast, ohnologs are only slightly,
although significantly, more prevalent in complexes than
expected by chance, 22% versus 19% (22%; 1,567/7,110; p =
9.0 3 1014, c2 test), whereas the proportion implicated in
cancer or disease genes is clearly enhanced 54% versus 39%
(54%; 3,844/7,110; p = 9.5 3 10140, c2 test).
To go beyond these simple statistical associations and quan-
tify the direct versus indirect effects of deleterious mutations and
dosage balance constraints on the biased retention of human
ohnologs, we have performed a Mediation analysis following
the approach of Pearl (Pearl, 2001, 2011). The Mediation frame-1392 Cell Reports 2, 1387–1398, November 29, 2012 ª2012 The Autwork, developed in the context of causal inference analysis, aims
at uncovering, beyond statistical correlations, causal pathways
along which changes in multivariate properties are transmitted
from a cause, X, to an effect, Y. More specifically, a Mediation
analysis assesses the importance of a mediator, M, in transmit-
ting the indirect effect of X on the response Y h Y(x,m(x))
(Figure 3B).
Mediation analyses have been typically used in social
sciences research (Baron and Kenny, 1986) as, for instance, in
the context of legal disputes over alleged discriminatory hiring.
In such cases, the problem is to establish that gender or race
(X) have directly influenced hiring (Y) and not simply indirectly
through differences in qualification or experience (M). Mediation
analyses have also been used in epidemiology, as in a formal
study (Robins and Greenland, 1992) that establishes the direct
effect of smoking (X) on the incidence of cardiovascular diseases
(Y), while taking into account the indirect effect of other aggra-
vating factors, such as hyperlipidemia (M).
In this report, we have applied the Mediation analysis to
genomic data to discriminate between direct effect (DE) and indi-
rect effect (IE) of deleterious mutations (X or M) and dosage
balance constraints (M or X) on the biased retention of human
ohnologs (Y). The results, derived in Extended Experimental
Procedures (Table S4) and summarized in Figure 3C and
Table S5, demonstrate that the retention of ohnologs in the
human genome is more directly caused by their susceptibility
to deleterious mutations than their interactions within multipro-
tein complexes.
Indeed, the direct causal effect of a change from ‘‘noncom-
plex’’ to ‘‘complex’’ proteins only accounts for 23% of a small
total effect (TE) of complex on the retention of ohnologs
(DE/TE = 23% with TE = 0.079), whereas 82% of this small total
effect is indirectly mediated by their susceptibility to deleterious
mutations (IE/TE = 82% with 5% nonlinear coupling between
direct and indirect effects) (Extended Results). By contrast, the
alternative hypothesis, assuming a direct effect of deleterious
mutations, accounts for 99% of a three times larger total effect
on ohnolog retention (DE/TE = 99% with TE = 0.23), whereas
the ‘‘complex’’ versus ‘‘noncomplex’’ status of human geneshors
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Figure 3. Mediation Analysis of the Indirect Effect of Deleterious Mutations on the Retention of Ohnologs in Multiprotein Complexes
(A) Enhanced susceptibility of complexes to deleterious mutations.
(B) Mediation diagram depicting the direct versus indirect (i.e., mediated) effects of the cause X on the outcome Y(x,m(x)) (Pearl, 2011). See also Extended
Experimental Procedures.
(C and D) Quantitative Mediation analysis of direct versus indirect effects of deleterious mutations and dosage balance on the retention of human ohnologs using
(C) all human genes (20,506) or (D) all human genes without SSD nor CNV (8,215). The thickness of the arrows outlines the relative importance of the corre-
sponding direct or indirect effects. These results are consistent with those obtained from partial correlation analysis.
See also the main text, Extended Results, and Tables S4, S5, and S6.has a negligible indirect effect on ohnolog retention in this case
(IE/TE = 2%) (Extended Results). These trends are also further
enhanced when the analysis is restricted to the 40% of human
genes (8,215) without SSD and CNV duplicates (Figure 3D; Table
S5; Extended Results). In fact, the direct effect of multiprotein
complexes then tends to oppose the retention of ohnologs
(DE/TE = 33% with TE = 0.064), as in the case of permanent
complexes detailed above, but on an increased sample size of
8,215 genes without SSD or CNV duplicates (i.e., more than
a third of human genes) in place of 239 genes from permanent
complexes. By contrast, there is a five times larger total effect
due to the direct effect of deleterious mutations on the retention
of ohnologs (DE/TE = 101%with TE = 0.32), Figure 3D. This is an
instance of Simpson’s paradox, where two effects oppose each
other, thereby, revealing the existence of conflicting underlying
causes, namely, a strong positive effect of deleterious mutations
and a small negative effect of dosage balance constraints on the
retention of human ohnologs without SSD and CNV duplicates.
We have also examined the effects of other alternative proper-
ties on the retention of ohnologs (Extended Results; Table S5). In
particular, we have found that gene expression levels and Ka/Ks
ratios do not significantly mediate the effect of deleterious muta-
tions on the retention of ohnologs. In fact, gene expression levels
(Extended Experimental Procedures) have a negligible total
effect on the retention of human ohnologs (TE = 0.003), by
contrast to what has been reported for the paramecium (GoutCell Reet al., 2009). The total effects of Ka/Ks on ohnolog retention
are also lower than the total effects of deleterious mutations,
as TEs from deleterious mutations are 2- to 3-fold stronger
than TEs from Ka/Ks and become >10-fold stronger for genes
without SSD and CNV (Extended Results).
In addition, we have performed a complementary systematic
study of all these genomics properties using partial correlation
analysis, which aims at ‘‘removing’’ the effect of a third property
(Z) on the standard pair correlations between two variables (X)
and (Y). The results detailed in Extended Results and Table S6
are entirely consistent with those obtained through mediation
analysis, although the two approaches are not equivalent.
Indeed, although mediation effects require partial correlation,
partial correlation does not imply mediation, in general
(Extended Results).
All in all, these results support the fact that the retention of
ohnologs in the human genome is more strongly associated
with their ‘‘dangerousness’’ (i.e., susceptibility to dominant dele-
terious mutations) than with their functional importance (‘‘essen-
tiality’’), sensitivity to dosage balance, absolute expression
levels or sequence conservation (i.e., Ka/Ks).
Model for the Retention of ‘‘Dangerous’’ Ohnologs
As demonstrated above, human genes with a documented
sensitivity to dominant deleterious mutations have retained
statistically more ohnologs from the two WGD events at theports 2, 1387–1398, November 29, 2012 ª2012 The Authors 1393
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deleterious mutations (C). See main text for a detailed description.onset of jawed vertebrates. This suggests that ohnologs have
been retained in vertebrate genomes, not because they initially
brought selective advantages following WGD, but because their
mutations were more likely detrimental or lethal than nonfunc-
tional, thereby preventing their rapid elimination from the
genomes of surviving individuals following WGD transitions, as
outlined in the evolutionary model depicted in Figure 4.
For completeness and clarity, Figure 4 examines all possible
evolutionary scenarios following either a SSD or a WGD duplica-
tion event in the genome of one or a few individuals in an initial
population. The first and critical difference between SSD and
WGD duplication events occurs at the population genetics level
with an obligate speciation following WGD event, owing to the
difference in ploidy between pre- and post-WGD individuals.
As a result, all individuals in the post-WGDpopulation carry twice
as many genes as their pre-WGD relatives, whereas only a few
individuals in the post-SSD population carry a single small dupli-
cated region. Figure 4 then outlines the three mutation/selection
scenarios focusing on a single gene duplicate in the genomes of1394 Cell Reports 2, 1387–1398, November 29, 2012 ª2012 The Autpost-SSD or post-WGD populations: (A) Beneficial mutations
after SSD or WGD are expected to spread and become eventu-
ally fixed in the new populations, although the bottleneck in
population size following WGD limits in practice the efficacy of
adaptation in post-WGD species. (B) Neutral or nearly neutral
mutations mainly lead to the random nonfunctionalization of
one copy of most redundant gene duplicates and, therefore, to
their elimination following both SSD and WGD events. In post-
WGD populations, this results in the ‘‘reciprocal gene loss’’ of
most gene duplicates, which is also known to lead to further
speciations in post-WGD species, owing to the interbreeding
incompatibility between post-WGD individuals with different
‘‘reciprocal gene loss’’ pattern (Lynch and Force, 2000a). Alter-
natively, neutral or nearly neutral mutations can also result in
the eventual retention of both duplicate copies through subfunc-
tionalization (Hughes, 1994; Lynch and Force, 2000b), that is, by
rendering each duplicate copy unable to perform all the func-
tions of their ancestral gene (see Discussion). (C) Finally, domi-
nant deleteriousmutations favor the elimination of the individualshors
(or their descendants) harboring them through purifying selec-
tion. However, this typically leads to opposite outcomes in
post-SSD and post-WGD populations. In post-SSD populations,
dominant deleterious mutations will tend to eliminate SSD dupli-
cates before they have the time to reach fixation (see below). By
contrast, in post-WGD populations, where all ohnologs have
been initially fixed through WGD-induced speciation, purifying
selection will effectively favor the retention of dangerous ohno-
logs, as all surviving individuals still present (nondeleterious)
functional copies of these dangerous genes.
Note, in particular, that this somewhat counterintuitive evolu-
tionary model for the retention of ‘‘dangerous’’ ohnologs hinges
on two unique features:
(1) It requires an autosomal dominance of deleterious muta-
tions, in agreement with our observation, above, that re-
tained ohnologs are more ‘‘dangerous’’ than ‘‘essential.’’
(2) It relies on the fact that successful WGD events start with
a concomitant speciation event, which immediately fixes
all ohnolog duplicates in the initial post-WGD population
(Figure 4).
Note, also, that the same evolutionary trend is expected for
dangerous SSD duplicates that would have the time (t) to
become fixed through genetic drift in a population of size N
before deleterious mutations can arise at a rate K, i.e., t = 4N <
1/K. This corresponds to a population bottleneck effect with
N < 1/(4K)z5,000–10,000 for typical vertebrates.DISCUSSION
Beyond human and vertebrate genomes, WGD events have
now been established in all major eukaryote kingdoms (Se´mon
and Wolfe, 2007; Evlampiev and Isambert, 2007). Unlike
SSD events, WGD transitions provide a unique evolutionary
mechanism, enabling the simultaneous duplication of entire
genetic pathways and multiprotein complexes, followed by
long periods of functional divergence and extensive loss of oh-
nologs (Aury et al., 2006). Moreover, although both WGD and
SSD events have expanded the gene repertoires and resulting
protein networks (Evlampiev and Isambert, 2007; Evlampiev
and Isambert, 2008) of eukaryotes, it has become increasingly
clear that WGD and SSD events actually lead to the expansion
of different gene classes in the course of evolution, (Maere
et al., 2005; Aury et al., 2006; Se´mon and Wolfe, 2007; Makino
and McLysaght, 2010; Huminiecki and Heldin, 2010; and this
study).
In this article, we report that WGD have effectively favored the
expansion of gene families prone to deleterious mutations in the
human genome, such as genes implicated in cancer and genes
with autoinhibitory interactions. In particular, we found that the
retention of many ohnologs suspected to be dosage balanced
is in fact indirectly mediated by their susceptibility to deleterious
mutations.
From a broader perspective, a number of studies have now
shown that many genomic properties, such as gene essentiality,
duplicability, functional ontology, network connectivity, expres-
sion level, mutational robustness, divergence rates, etc., allCell Reappear to be correlated to some extent. In the light of the present
study, we expect that many of these statistically significant
correlations mainly result from indirect rather than direct associ-
ations, which may even frequently oppose each other. This high-
lights the need to rely on more advanced inference methods to
analyze the multiple, direct, and indirect causes underlying the
evolution of specific gene repertoires.
In the present study, we have quantitatively analyzed the direct
versus indirect effects of the susceptibility of human genes to
deleterious mutation and dosage balance constraints on the
retention of ohnologs and proposed a simple evolutionary mech-
anism to account for the initial retention of ‘‘dangerous’’ ohno-
logs after WGD (Figure 4). On longer timescales, we expect
that this initial retention bias of ‘‘dangerous’’ ohnologs effectively
promote a prolonged genetic drift and, thus, a progressive func-
tional divergence between ohnolog pairs. This eventually favors
the subfunctionalization (Hughes, 1994; Lynch and Force,
2000b) of ancestral functions between ohnolog pairs, which ulti-
mately warrants their long-term maintenance following WGD
events.
Note, however, that this subfunctionalization process requires
that the expression of ohnologs is not rapidly suppressed by
large-scale deletion or silencing mutations in regulatory regions.
As ohnolog pairs are not arranged in tandem, large-scale dele-
tions through unequal crossing-over cannot typically remove
entire ohnolog duplicates while preserving the integrity of nearby
genes. Furthermore, as the size of promoter or enhancer regions
is typically much smaller than UTRs and coding regions, one
expects that the rate of transcriptional silencing does not exceed
the rates of functional silencing and divergence in UTRs and
coding regions. In fact, early estimates (Nadeau and Sankoff,
1997) showed that gene loss and functional divergence after
genome duplications in early vertebrates occurred at compa-
rable rates in gene families including at least two ohnologs.
This is also directly evidenced by pseudotetraploid species like
the vertebrate Xenopus laevis, which still retains 40% of its
initial ohnologs from a 30-million-year-old WGD (Se´mon and
Wolfe, 2008). All in all, this suggests that ohnologs prone to
dominant deleterious mutations have at least a few million years
to diverge and become nonredundant genes before they have
a chance to be deleted or transcriptionally silenced.
Yet, we found that the retention of these dangerous ohnologs
remains intrinsically stochastic by nature as many of them have
also been eliminated following WGD events. This presumably
occurred through loss-of-function mutations, transcriptional
silencing, or large-scale deletion before ohnolog pairs could
diverge and become nonredundant genes. More quantitatively,
a simple theoretical estimate, derived from the long-term reten-
tion statistics of Figure 1, shows that only 6%–10% of the initial
ohnolog duplicates have been retained on average at each round
of WGD, Figure 5 (see Extended Results for details). By compar-
ison, 23%–30% of the initial ohnologs prone to gain-of-func-
tion mutations have been retained on average at each WGD.
This implies that genes susceptible to deleterious mutations
are two to five timesmore likely to retain ohnologs on long evolu-
tionary timescales. Moreover, genes combining several factors
associated with enhanced susceptibility to autosomal-dominant
deleterious mutations are shown to be more than ten times moreports 2, 1387–1398, November 29, 2012 ª2012 The Authors 1395
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as detailed in the Extended Results and
Tables S7 and S8.likely to retain ohnologs than genes lacking gain-of-function
mutations (Figure 5), as illustrated on the examples of oncogenes
with autoinhibitory folds (Table 1).
In turn, the elimination of ohnologs has been shown to drive
further speciation events within post-WGD (sub)populations,
due to the emergence of recombination barriers from the accu-
mulation of differences in ohnolog deletion patterns between
post-WGD individuals (Lynch and Force, 2000a). The resulting
fragmentation of post-WGD subpopulations is then expected
to sustain negative selection pressure that favors the retention
of the remaining ohnolog pairs prone to deleterious mutations,
as outlined in Figure 4. Hence, although most WGDs are unlikely
to bring much fitness benefit on short evolutionary timescales (if
only due to the population bottlenecks associated with WGD-
induced speciations; Figure 4), they provide a unique evolu-
tionary mechanism to experiment virtually unlimited combina-
tions of regulation/deletion patterns from redundant ohnolog
genes. Over long timescales (>100–500 MY), such trial and error
combinations have visibly led to the evolutionary success and
radiation of WGD species.
In summary, we present evidence supporting an evolutionary
link between the susceptibility of human genes to dominant dele-
terious mutations and the documented expansion of these
‘‘dangerous’’ gene families by two WGD events at the onset of
jawed vertebrates. We propose that deleterious mutations,
responsible for many cancers and other severe genetic diseases
on the lifespan of human individuals, have also underlain puri-
fying selection over long evolutionary timescales, which effec-
tively favored the retention of vertebrate ohnologs prone to
dominant deleterious mutations, as outlined in Figure 4. From
a population genetics perspective, we argue that this counterin-
tuitive retention of dangerous ohnologs hinges in fact on WGD-1396 Cell Reports 2, 1387–1398, November 29, 2012 ª2012 The Autinduced speciation events, which are largely credited for the
genetic complexity and successful radiation of vertebrate
species.
These findings highlight the importance of purifying selection
from WGD events on the evolution of vertebrates and, beyond,
exemplify the role of nonadaptive forces on the emergence of
eukaryote complexity (Ferna´ndez and Lynch, 2011).
EXPERIMENTAL PROCEDURES
WGD Duplicated Genes or ‘‘Ohnologs’’
Human ohnolog genes were obtained from (Makino and McLysaght, 2010).
Makino and McLysaght compared different vertebrate and six nonvertebrate
outgroup genomes to identify ohnologs in the human genome. The final data
set consists of 8,653 ohnolog pairs and 7,110 unique ohnologs. We further
divided ohnologs into well supported (3,963), plausible (894), and more uncer-
tain (2,253) ohnologs (see Extended Experimental Procedures).
SSD Duplicated Genes
We identified paralogous genes within the human genome from sequence
similarity search. We obtained a total of 11,185 SSD genes. In particular,
paralogs that were not annotated as ohnologs were taken to be SSD genes
(see Extended Experimental Procedures).
Genes with CNV
CNV regions were obtained from Database of Genomic Variants (Zhang et al.,
2006). A total of 5,709 genes were identified to be CNV genes as their entire
coding sequence fell within one of the CNV regions.
Cancer and Disease Genes
We obtained cancer genes from multiple databases, including COSMIC (For-
bes et al., 2011) and CancerGenes (Higgins et al., 2007), listed in Table S7. The
detailed list of 6,917 cancer genes is given in Table S8 with a hand-curated list
of 813 verified or predicted (Bozic et al., 2010) oncogenes (see Extended
Experimental Procedures). We obtained 2,580 disease genes from the ‘‘Mor-
bidmap’’ database of OMIM and hand curated subsets of 440 autosomal-
dominant and 598 autosomal-recessive disease genes from Blekhman et al.
(2008).
Genes with Autoinhibitory Folds
To obtain genes coding for proteins with autoinhibitory folds we searched
PubMed with keyword ‘‘autoinhibitory domain’’ and retrieved relevant autoin-
hibitory genes and domains manually. Further gene candidates with autoinhi-
bitory folds were obtained from databases, OMIM, SwissProt, NCBI Gene, and
GeneCards using the parsing terms: auto/self-inhibit*. Careful manual curation
of this list of gene candidates with the available literature finally yielded a total
of 461 genes with autoinhibitory folds (94% of initial candidates).
Essential Genes
Mouse essential genes were obtained from Mouse Genome Informatics data-
base. Essential genes were defined as genes having lethal or infertility pheno-
types on loss-of-function or knockout mutations (2,729 genes) (see Extended
Experimental Procedures).
Genes in Complexes and Permanent Complexes
Protein complexes were obtained from Human Protein Reference Database
(HPRD) (Keshava Prasad et al., 2009) and CORUM database (Ruepp et al.,
2010). In addition, a manually curated data set of permanent complexes
(239 genes) was obtained from Zanivan et al. (2007). The final data set consists
of 3,814 protein complex genes (see Extended Experimental Procedures).
Haploinsufficient and Dominant Negative Genes
Haploinsufficient and dominant negative candidate genes were obtained from
parsing OMIM text files with Perl regular expressions. The resulting gene lists
were manually curated with the available literature, yielding a total ofhors
330 haploinsufficient genes (80% of initial candidates) and 477 dominant-
negative genes (63% of initial candidates).
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